Epharmix Announces Strategic Investment from UnityPoint Health

October 11, 2019 / Nueterra Capital Marketing

Epharmix | A Nueterra Capital Portfolio Company

Nueterra Capital portfolio company Epharmix recently announced an investment from UnityPoint Health Ventures, the investment arm of health system Unity Point Health. Epharmix uses evidence-based check-ins to collect patient-reported symptoms and biometrics to engage patients and monitor chronic and behavioral health conditions. You can read the full article here.